MORGAN STANLEY

Position in SRZN — Surrozen, Inc./DE

CIK 895421 NEW YORK, NY

Position in SRZN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$653,851

-$181,466 QoQ

Shares Held

22,446

-39.3% QoQ

Ownership

0.193%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#38

of 58 holders

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 97.56304018533369.ToString("F0")% Shared 0.ToString("F0")% None 2.4369598146663103.ToString("F0")%

Healthcare · as of Mar 31, 2026

MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. SRZN ranks #279 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	43,571,633	$2,090,131,227
2	ROIV	Roivant Sciences Ltd.	51,828,325	$1,435,644,595
3	VRTX	Vertex Pharmaceuticals Inc / Ma	3,188,881	$1,423,962,911
4	REGN	Regeneron Pharmaceuticals, Inc.	1,319,329	$1,019,366,352
5	TECH	BIO-TECHNE Corp	8,532,873	$445,927,935
6	MRNA	Moderna, Inc.	8,471,263	$430,340,154
7	ARGX	Argenx SE	560,711	$409,459,203
8	APLS	Apellis Pharmaceuticals, Inc.	10,042,399	$404,005,708

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$653,851	22,446	-39.3%	Shares	Defined	2026-05-15
2025-12-31	$835,317	36,961	+6.3%	Shares	Defined	2026-05-27
2025-09-30	$447,933	34,764	0.0%	Shares	Defined	2026-05-27
2025-06-30	$310,790	34,764	0.0%	Shares	Defined	2025-08-15
2025-03-31	$405,347	34,764	0.0%	Shares	Defined	2025-05-15
2024-12-31	$498,862	34,764	-1.3%	Shares	Defined	2025-05-15
2024-09-30	$421,827	35,211	0.0%	Shares	Defined	2025-05-14
2024-06-30	$385,560	35,211	0.0%	Shares	Defined	2025-05-14
2024-03-31	$553,164	35,211	0.0%	Shares	Defined	2024-10-17
2023-12-31	$330,983	35,211	—	Shares	Defined	2024-08-16
No filing history on record for this holder in this stock.